The present invention discloses a novel use of magnesium oxide and magnesium hydroxide formulation in adequate proportions and sufficient amounts to induce bowel movement to induce the excretion of HIV, along with HIV-infected pathogens present in the intestinal tract of HIV-infected persons, and to induce the excretion of HIV-loaded bile from said persons. The present invention may prevent the development of drug resistance in HIV patients undergoing drug therapy, may accelerate the recovery of HIV-infected patients, may permit full recovery of these individuals, may prevent viral mutation of patients undergoing HIV drug therapy, and may prevent the onset of AIDS in HIV-infected patients. As an additional benefit, the present invention will contribute to the prevention of adipose tissue disorders, frequently seen in persons undergoing drug therapy. The present invention may be used by itself or together with HAART or other drug therapies.